5 Biotechs Drawing Buyout Buzz in 2018 Post author:Sam Post published:January 23, 2018 Post category:BioPharma Here are five possible acquisition targets to keep an eye on. Source: BioSpace You Might Also Like As the IDO Battle Gets Ugly, Bristol-Myers Shows Off Early Data for Combo Trial November 9, 2017 Leap Therapeutics Reports Second Quarter 2017 Financial Results August 10, 2017 This Small Massachusetts Biotech Soared to a 20-Month High on Its Celgene-Partnered Trial June 6, 2017
This Small Massachusetts Biotech Soared to a 20-Month High on Its Celgene-Partnered Trial June 6, 2017
